Delivery Order SPE2DB22D2007-SPE2DB25FJ3PL
- Not listed
- The Defense Logistics Agency awarded a $4,719.34 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Prevymis 480 mg tablets (7-count packages). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 10, 2025, and represents a child order under AmerisourceBergen's larger federal contract vehicle. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Prevymis 480 mg tablets in seven-tablet packages, with a contract ceiling value of $9,438.70 and a firm fixed price structure. This non-set-aside delivery order is scheduled for completion by September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's ongoing...
- The Defense Logistics Agency awarded a $4,719.34 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Prevymis 480 mg tablets (7-count packaging). This is a firm fixed-price contract with an ultimate completion date of August 15, 2025, and represents a non-set-aside, competitively awarded procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Prevymis 480 mg tablets in quantities of seven units. This competitively awarded, firm fixed-price contract carries a ceiling value of $9,438.70 and is scheduled for completion by August 22, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $4,719.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for PREVYMIS 480 mg tablets (7-count) on June 18, 2025, with an ultimate completion date of July 11, 2025. This non-set-aside competitive award reflects the pharmaceutical distributor's capability to meet federal medical procurement requirements. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems,...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Prevymis 480 mg tablets in quantities of seven units, with a ceiling value of $4,719.34. The delivery order utilizes firm fixed price pricing and is scheduled for ultimate completion by August 18, 2025. This non-set-aside award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Prevymis 480 mg tablets in a quantity of seven units, with a total ceiling value of $4,719.34. This firm fixed-price delivery order is scheduled for completion by October 2, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $4.72K firm fixed-price delivery order to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (7-count units) with an ultimate completion date of August 26, 2025. This non-set-aside contract was competitively awarded on August 5, 2025, and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Prevymis 480 mg tablets (7-count packages) valued at $4,719.34. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 23, 2025, with performance at the contractor's corporate headquarters in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order falls under...
- The Defense Logistics Agency awarded a $9,438.70 firm fixed price delivery order to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (quantity 7) on September 3, 2025, with an ultimate completion date of September 24, 2025. This non-set-aside competitive award is performed at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ3PLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,719.34 to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (7-count units) with an ultimate completion date of August 25, 2025. This is a firm fixed price, non-set-aside contract that represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems, serving as a prime contractor for comprehensive pharmaceutical and medical supply procurement across multiple therapeutic domains. This delivery order exemplifies AmerisourceBergen's role as a key supplier within DLA's pharmaceutical supply chain, fulfilling competitive awards for specialized medications and medical commodities. The company's SPE2DX indefinite delivery vehicle serves as a global pharmaceutical support mechanism enabling supply of brand-name and generic medications, vaccines, and medical devices to support military healthcare programs and other federal healthcare systems including the Defense Health Agency and U.S. Coast Guard. The DLA Troop Support Medical has indicated plans to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, positioning AmerisourceBergen among select vendors supporting this strategic procurement initiative.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 8/4/25 |